Autism clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
CM-AT for the Treatment of Children With Autism
Sorry, in progress, not accepting new patients
This is a Phase III, open label extension study evaluating the continued safety and efficacy of CM-AT in pediatric patients with autism with all levels of fecal chymotrypsin.
San Francisco, California and other locations
Our lead scientists for Autism research studies include Robert Hendren, DO.
Last updated: